Boston Medical Sciences, Inc. develops medical devices and healthcare AI technology, focusing on AI-powered, non-invasive colorectal cancer screening systems.
Global Brain made an additional investment in Boston Medical Sciences, Inc. as co-lead investor. BMS develops AI technology for laxative-free CT colonography for colorectal cancer screening.